MARKET

ATHX

ATHX

Athersys
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.390
0.000
0.00%
Closed 16:00 11/18 EST
OPEN
1.420
PREV CLOSE
1.390
HIGH
1.440
LOW
1.370
VOLUME
657.54K
TURNOVER
--
52 WEEK HIGH
2.150
52 WEEK LOW
1.200
MARKET CAP
217.77M
P/E (TTM)
-4.4651
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ATHX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ATHX News

  • Athersys, Inc. 2019 Q3 - Results - Earnings Call Presentation
  • Seeking Alpha - Article.4d ago
  • Athersys, Announces Healios Receives Notification of Orphan Designation for Acute Respiratory Distress Syndrome Clinical Program in Japan
  • Benzinga.4d ago
  • Healios Receives Notification of Orphan Designation for Acute Respiratory Distress Syndrome Clinical Program
  • GlobeNewswire.4d ago
  • Were Hedge Funds Right About Souring On Athersys, Inc. (ATHX)?
  • Insider Monkey.11/11 14:30

More

Industry

Biotechnology & Medical Research
+0.32%
Pharmaceuticals & Medical Research
+0.13%

Hot Stocks

Name
Price
%Change

About ATHX

Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the standard of care is limited or inadequate for many patients.
More

Webull offers Athersys, Inc. (ATHX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.